Home > Divisions > Pulmonary and Sleep Medicine > Research > Duke Asthma Clinical Research Center

Duke Asthma Clinical Research Center

AddThis

"share
Print

email this

Welcome

The American Lung Association (ALA) supports an Asthma Clinical Research Center (ACRC) at Duke University Medical Center--the ALA-ACRC. The Center involves three divisions at Duke:
The Principal Investigator is:
 
John Sundy, MD, PhD
Department of Medicine
Division of Pulmonary, Allergy and Critical Care
Duke University Medical Center
Box 3278
Durham, NC 27710
Tel: 919.668.2169
Fax: 919.681.8298

The national office of the American Lung Association and its affiliated Lung Associations around the country, including the American Lung Association of North Carolina, support a network of twenty Asthma Clinical Research Centers. This initiative brings together a nationwide corps of scientists and medical researchers with clinical expertise in asthma with a goal of improving clinical care for asthma.
 

About the ACRC

The ALA-ACRC develops and performs clinical research studies of asthma patients including a broad range of age groups with appropriate gender and minority representation. Duke University Medical Center is the ACRC for North Carolina. The research conducted at the Center will potentially lead to major advances in the understanding and prevention of asthma, which will contribute many times over to alleviating suffering and reducing health care costs.

The Asthma Research Initiative is the American Lung Association's nationwide effort to improve the treatment of asthma and, ultimately, to find a cure. The Asthma Research Initiative is sponsored by the national ALA with contributions from local American Lung Association (ALA) offices throughout the country, including the American Lung Association of North Carolina. The ALA-ACRC opened in July 1999 to conduct clinical research trials on large numbers of asthma patients.

The Duke Asthma Clinical Research Center is dedicated to quality research for the treatment of asthma and allergy related diseases. The ACRC is staffed by Pediatric and Internal Medicine Physicians, Nurses, and Respiratory Therapists. Clinical trials are conducted in both children and adults.
"Breathing less is not an option"
We hope to help sustain the life and breath of asthma patients, but we depend on the help of people with asthma to enroll in our studies to be part of the cure.

Current Clinical Trials

The Duke Asthma Clinical Research Center is seeking participants for asthma research studies. Studies are sponsored by the American Lung Association, often in collaboration with the NIH and pharmaceutical companies. The following studies are currently ongoing.

Could SOY Improve your Asthma?

If you are age 12 or older, under the care of a physician and taking daily asthma medications, you may be eligible to participate in a research study evaluating the effects of SOY supplements on asthma at the Duke Clinical Research Unit. The study involves nine visits over six months, and qualified participants will be compensated.  

For further infomation, please call 919-613-6246 or email dcru.org/volunteer.

Ref # e-00019125)


Could Allergies be Affecting your Asthma?

If you, or your child who is 6 to17 years old, are under the care of a physician, taking asthma medications and still having chronic allergic rhinitis or sinusitis, you or your child may be eligible to participate in a study of asthma and nasal steroids (STAN) at the Duke Clinical Research Unit. Participants will receive study medication, lung function testing, allergy skin testing and compensation for participation. The study involves five visits and three phone calls over six to seven months.

For information, please call 919-613-6246 or email dcrurecruit@duke.edu.

Ref # e-00019395)


Study of Acid Reflux in Children with Asthma (SARCA Study)

[Enrollment Closed]

What is the purpose of this study? 
Physicians at the Duke Asthma Clinical Research Center (ACRC) are studying acid reflux (GER) and asthma. Asthma may be hard to control because of GER. Children with asthma may be eligible for the study even without symptoms of acid reflux.
 
What does this study involve? 
The study involves nine visits over a six month time period. Individuals 6 to 17 years old may be eligible to participate in this study.

Subjects receive:
  • Testing for gastroesophageal reflux (GER)
  • Study medication
  • Lung function testing
  • Compensation for participation

For further infomation, please call Catherine Foss, RRT, CCRC or Denise Jaggers, RN at 919-684-0191. If you are interested in participating in this study, email DukeACRC@mc.duke.edu and provide your contact information (email and/or phone number). A research coordinator will follow up with you by phone.

Ref # e-0739)

 

 Resources